For: | To KK, Tong CW, Wu M, Cho WC. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside. World J Gastroenterol 2018; 24(27): 2949-2973 [PMID: 30038463 DOI: 10.3748/wjg.v24.i27.2949] |
---|---|
URL: | https://www.wjgnet.com/2150-5349/full/v24/i27/2949.htm |
Number | Citing Articles |
1 |
Yiming Wang, Lumi Huang, Nan Shan, Huiwen Ma, Songmei Lu, Xingyue Chen, Hao Long. Establishing a three-miRNA signature as a prognostic model for colorectal cancer through bioinformatics analysis. Aging 2021; 13(15): 19894 doi: 10.18632/aging.203400
|
2 |
Kodappully S. Siveen, Afsheen Raza, Eiman I. Ahmed, Abdul Q. Khan, Kirti S. Prabhu, Shilpa Kuttikrishnan, Jericha M. Mateo, Hatem Zayed, Kakil Rasul, Fouad Azizi, Said Dermime, Martin Steinhoff, Shahab Uddin. The Role of Extracellular Vesicles as Modulators of the Tumor Microenvironment, Metastasis and Drug Resistance in Colorectal Cancer. Cancers 2019; 11(6): 746 doi: 10.3390/cancers11060746
|
3 |
Longyang Liu, Yingxia Ning, Juanjuan Yi, Jianhuan Yuan, Weiyi Fang, Zhongqiu Lin, Zhaoyang Zeng. miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression. Biomedicine & Pharmacotherapy 2020; 125: 109865 doi: 10.1016/j.biopha.2020.109865
|
4 |
Vivian Weiwen Xue, Cesar Sze Chuen Wong, William Chi Shing Cho. Early detection and monitoring of cancer in liquid biopsy: advances and challenges. Expert Review of Molecular Diagnostics 2019; 19(4): 273 doi: 10.1080/14737159.2019.1583104
|
5 |
Amir Abbas Hamidi, Malihe Zangoue, Daniel Kashani, Amir Sadra Zangouei, Hamid Reza Rahimi, Mohammad Reza Abbaszadegan, Meysam Moghbeli. MicroRNA-217: a therapeutic and diagnostic tumor marker. Expert Review of Molecular Diagnostics 2022; 22(1): 61 doi: 10.1080/14737159.2022.2017284
|
6 |
Jonathan W. Villanueva, Lawrence Kwong, Teng Han, Salvador Alonso Martinez, Michael T. Shanahan, Matt Kanke, Lukas E. Dow, Charles G. Danko, Praveen Sethupathy. Comprehensive microRNA analysis across genome-edited colorectal cancer organoid models reveals miR-24 as a candidate regulator of cell survival. BMC Genomics 2022; 23(1) doi: 10.1186/s12864-022-09018-1
|
7 |
Yu Sun, Yan Cheng, Yan Zhang, Kun Han. MicroRNA‑889‑3p targets FGFR2 to inhibit cervical cancer cell viability and invasion. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7675
|
8 |
Kenneth K.W. To, Winnie Fong, Christy W.S. Tong, Mingxia Wu, Wei Yan, William C.S. Cho. Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments. Expert Opinion on Drug Discovery 2020; 15(1): 63 doi: 10.1080/17460441.2020.1690449
|
9 |
Xiaolin Zhang, Zhen Dong, Hongjuan Cui. Interplay between Epigenetics and Cellular Metabolism in Colorectal Cancer. Biomolecules 2021; 11(10): 1406 doi: 10.3390/biom11101406
|
10 |
Li Huang, Wanjun Ding, Hongxue Wu, Jia Zheng. miR-497/195 Cluster Affects the Development of Colorectal Cancer by Targeting FRA1. Molecular Biotechnology 2024; 66(5): 1019 doi: 10.1007/s12033-023-01000-w
|
11 |
Junyue Chen, Tingting Fan, Yan Chen, Lizhen Ye, Chen Zhang, Feng Liu, Ying Qin, Ying Tan, Yuyang Jiang. Zeptomolar-level one-pot simultaneous detection of multiple colorectal cancer microRNAs by cascade isothermal amplification. Biosensors and Bioelectronics 2020; 169: 112631 doi: 10.1016/j.bios.2020.112631
|
12 |
Susana Ourô, Cláudia Mourato, Sónia Velho, André Cardador, Marisa P. Ferreira, Diogo Albergaria, Rui E. Castro, Rui Maio, Cecília M. P. Rodrigues. Potential of miR-21 to Predict Incomplete Response to Chemoradiotherapy in Rectal Adenocarcinoma. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.577653
|
13 |
Jiaqi Wang, Yuhki Yokoyama, Haruka Hirose, Yuki Shimomura, Saki Bonkobara, Hiroaki Itakura, Shihori Kouda, Yoshihiro Morimoto, Kazumasa Minami, Hidekazu Takahashi, Satoshi Shibata, Shogo Kobayashi, Mamoru Uemura, Susumu Tanaka, Xin Wu, Shinji Tanaka, Masaki Mori, Hirofumi Yamamoto. Functional assessment of miR‑1291 in colon cancer cells. International Journal of Oncology 2022; 60(2) doi: 10.3892/ijo.2022.5303
|
14 |
N. Helge Meyer, Nika Kotnik, Gaetan Aime Noubissi Nzeteu, Léon C. van Kempen, Mirjam Mastik, Maximilian Bockhorn, Achim Troja. Unraveling the MicroRNA tapestry: exploring the molecular dynamics of locoregional recurrent rectal cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1407217
|
15 |
Yufei Tang, Shaoqi Zong, Hailun Zeng, Xiaofeng Ruan, Liting Yao, Susu Han, Fenggang Hou. MicroRNAs and angiogenesis: a new era for the management of colorectal cancer. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01920-0
|
16 |
Xiaorui Cui, Mingpeng Li, Zhengchu He, Lin Hu, Jianping Liu, Jianhui Yan, Liming Hua. MiR‐302b‐5p enhances the neuroprotective effect of IGF‐1 in methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced Parkinson's disease by regulating inducible nitric‐oxide synthase. Cell Biochemistry and Function 2020; 38(8): 1025 doi: 10.1002/cbf.3534
|
17 |
Veronika Hanusova, Petra Matouskova, Monika Manethova, Jiri Soukup, Stanislav John, Martin Zofka, Hana Vošmikova, Lukas Krbal, Emil Rudolf. Comparative Analysis of miRNA and EMT Markers in Metastatic Colorectal Cancer. Cancer Investigation 2023; 41(10): 837 doi: 10.1080/07357907.2023.2283495
|
18 |
Valeria Lucarini, Daniela Nardozi, Valentina Angiolini, Monica Benvenuto, Chiara Focaccetti, Raffaele Carrano, Zein Mersini Besharat, Roberto Bei, Laura Masuelli. Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion. Biomedicines 2023; 11(6): 1761 doi: 10.3390/biomedicines11061761
|
19 |
Yuan Fang, XiaoLi Zhang, HanFei Huang, Zhong Zeng. The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04238-9
|
20 |
Wen-Yan Mo, Shi-Qiong Cao. MiR-29a-3p: a potential biomarker and therapeutic target in colorectal cancer. Clinical and Translational Oncology 2022; 25(3): 563 doi: 10.1007/s12094-022-02978-6
|
21 |
Hersh Ham-Karim, Ola Negm, Narmeen Ahmad, Mohammad Ilyas. Investigating genomic, proteomic, and post-transcriptional regulation profiles in colorectal cancer: a comparative study between primary tumors and associated metastases. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03020-7
|
22 |
Chen Liang, Jing-Bo Yang, Xin-Yi Lin, Bi-Lan Xie, Yun-Xian Xu, Shu Lin, Tian-Wen Xu. Recent advances in the diagnostic and therapeutic roles of microRNAs in colorectal cancer progression and metastasis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.911856
|
23 |
Qing‐Tao Zou, Yi Lin, Qing‐Yu Luo. miR‐138‐5p inhibits the progression of colorectal cancer via regulating SP1/LGR5 axis. Cell Biology International 2023; 47(1): 273 doi: 10.1002/cbin.11926
|
24 |
Jun Shibamoto, Tomohiro Arita, Hirotaka Konishi, Satoshi Kataoka, Hirotaka Furuke, Wataru Takaki, Jun Kiuchi, Hiroki Shimizu, Yusuke Yamamoto, Shuhei Komatsu, Atsushi Shiozaki, Yoshiaki Kuriu, Eigo Otsuji. Roles of miR-4442 in Colorectal Cancer: Predicting Early Recurrence and Regulating Epithelial-Mesenchymal Transition. Genes 2023; 14(7): 1414 doi: 10.3390/genes14071414
|
25 |
Dong-Yan Zhao, Teng-Fei Yin, Xi-Zhen Sun, Yuan-Chen Zhou, Qian-Qian Wang, Ge-Yujia Zhou, Shu-Kun Yao. microRNA-627-5p inhibits colorectal cancer cell proliferation, migration and invasion by targeting Wnt2. World Journal of Gastrointestinal Oncology 2023; 15(2): 318-331 doi: 10.4251/wjgo.v15.i2.318
|
26 |
Pengqiang Zhong, Jiali Wu, Xingxing Yan, Yin Liu, Ruizhi Wang, Dong Wang. Prognostic Nomogram for Colorectal Cancer Patients After Surgery. Indian Journal of Surgery 2023; 85(5): 1184 doi: 10.1007/s12262-023-03712-4
|
27 |
Laura Imedio, Ion Cristóbal, Jaime Rubio, Andrea Santos, Federico Rojo, Jesús García-Foncillas. MicroRNAs in Rectal Cancer: Functional Significance and Promising Therapeutic Value. Cancers 2020; 12(8): 2040 doi: 10.3390/cancers12082040
|
28 |
Yaru Wang, Yanting Li, Xin Li. Ultrasound microbubble-mediated miR-503–5p downregulation suppressed in vitro CRC progression via promoting SALL1 expression. Tissue and Cell 2022; 76: 101811 doi: 10.1016/j.tice.2022.101811
|
29 |
Katerina Kampoli, Periklis G Foukas, Anastasios Ntavatzikos, Nikolaos Arkadopoulos, Anna Koumarianou. Interrogating the interplay of angiogenesis and immunity in metastatic colorectal cancer. World Journal of Methodology 2022; 12(1): 43-53 doi: 10.5662/wjm.v12.i1.43
|
30 |
Gavin M. Traber, Ai-Ming Yu. RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies. Journal of Pharmacology and Experimental Therapeutics 2023; 384(1): 133 doi: 10.1124/jpet.122.001234
|
31 |
Jiayu Chen, Ji Sun, Ye Yuan, Haolin Wang, Sihan Kang, Abdulrab Ahmed M. Alkhanjaf, Yiling Li, Dianbao Zhang. miR-9 Maintains Cell Migration and Proliferation of Colorectal Cancer Cells by Targeting Repressor Element-1 Silencing Transcription Factor (REST). Science of Advanced Materials 2022; 14(3): 440 doi: 10.1166/sam.2022.4221
|
32 |
Chao Yu, Deguan Li, Qiang Yan, Yigao Wang, Xiaodong Yang, Shangxin Zhang, Yonghong Zhang, Zhen Zhang. Circ_0005927 Inhibits the Progression of Colorectal Cancer by Regulating miR-942-5p/BATF2 Axis. Cancer Management and Research 2021; : 2295 doi: 10.2147/CMAR.S281377
|
33 |
Romain Chautard, Laetitia Corset, Sajida Ibrahim, Céline Desvignes, Gilles Paintaud, Nadine Baroukh, Maxime Guéguinou, Thierry Lecomte, William Raoul. Panitumumab and Cetuximab Affect Differently Mirna Expression in Colorectal Cancer Cells. Biomarkers in Medicine 2021; 15(10): 685 doi: 10.2217/bmm-2020-0520
|
34 |
Weiliang Li, Youqi Xu, Xiaodong Wang, Guang Cao, Wenjing Bu, Xia Wang, Zhen Fang, Yao Xu, Mengjia Dong, Qianyi Tao. circCCT3 Modulates Vascular Endothelial Growth Factor A and Wnt Signaling to Enhance Colorectal Cancer Metastasis Through Sponging miR-613. DNA and Cell Biology 2020; 39(1): 118 doi: 10.1089/dna.2019.5139
|
35 |
Komal Abhange, Amy Makler, Yi Wen, Natasha Ramnauth, Wenjun Mao, Waseem Asghar, Yuan Wan. Small extracellular vesicles in cancer. Bioactive Materials 2021; 6(11): 3705 doi: 10.1016/j.bioactmat.2021.03.015
|
36 |
Elham Kashani, Mahrooyeh Hadizadeh, Vahid Chaleshi, Reza Mirfakhraie, Chris Young, Sanaz Savabkar, Shiva Irani, Hamid Asadzadeh Aghdaei, Maziar Ashrafian Bonab. The Differential DNA Hypermethylation Patterns of microRNA-137 and microRNA-342 Locus in Early Colorectal Lesions and Tumours. Biomolecules 2019; 9(10): 519 doi: 10.3390/biom9100519
|
37 |
Jie Li, Wen Peng, Peng Yang, Ranran Chen, Qiou Gu, Wenwei Qian, Dongjian Ji, Qingyuan Wang, Zhiyuan Zhang, Junwei Tang, Yueming Sun. MicroRNA-1224-5p Inhibits Metastasis and Epithelial-Mesenchymal Transition in Colorectal Cancer by Targeting SP1-Mediated NF-κB Signaling Pathways. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00294
|
38 |
Molly A. Lausten, Bruce M. Boman. A Review of IsomiRs in Colorectal Cancer. Non-Coding RNA 2023; 9(3): 34 doi: 10.3390/ncrna9030034
|
39 |
Longhai Li, Lihua Zhang, Yu Tian, Ting Zhang, Guangliang Duan, Yankui Liu, Yuan Yin, Dong Hua, Xiaowei Qi, Yong Mao. Serum Chemokine CXCL7 as a Diagnostic Biomarker for Colorectal Cancer. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00921
|
40 |
Pauline Parent, Romain Cohen, Elie Rassy, Magali Svrcek, Julien Taieb, Thierry André, Anthony Turpin. A comprehensive overview of promising biomarkers in stage II colorectal cancer. Cancer Treatment Reviews 2020; 88: 102059 doi: 10.1016/j.ctrv.2020.102059
|
41 |
Prasanna Srinivasan Ramalingam, Deepak B. Thimiri Govinda Raj, Murugan Subramanian, Sivakumar Arumugam, Chandrabose Selvaraj. ML‐Based Screening of miRNA Inhibitors and Intervention of lncRNA/miRNA/mRNA Axis in Oncogenic KRAS‐Associated Colorectal Cancer. Advances in Public Health 2024; 2024(1) doi: 10.1155/2024/9436238
|
42 |
Lingchuan Guo, Jianhong Fu, Shimei Sun, Minsheng Zhu, Lifeng Zhang, Hui Niu, Zhi Chen, Yongsheng Zhang, Lingling Guo, Shouli Wang. MicroRNA‐143‐3p inhibits colorectal cancer metastases by targeting ITGA6 and ASAP3. Cancer Science 2019; 110(2): 805 doi: 10.1111/cas.13910
|
43 |
Kha Wai Hon, Norahayu Othman, Ezanee Azlina Mohamad Hanif, Siti Nurmi Nasir, Nur Syahada Abd Razak, Rahman Jamal, Nadiah Abu. Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies. 2020; : 135 doi: 10.1016/B978-0-12-819937-4.00008-X
|
44 |
Somayeh Igder, Mozhdeh Zamani, Shima Fakher, Morvarid Siri, Hassan Ashktorab, Negar Azarpira, Pooneh Mokarram, Sowjanya Thatikonda. Circulating Nucleic Acids in Colorectal Cancer: Diagnostic and Prognostic Value. Disease Markers 2024; 2024: 1 doi: 10.1155/2024/9943412
|
45 |
Amir Sadra Zangouei, Faezeh Tolue Ghasaban, Amin Dalili, Iman Akhlaghipour, Meysam Moghbeli. MicroRNAs as the pivotal regulators of Forkhead box protein family during gastrointestinal tumor progression and metastasis. Gene Reports 2022; 29: 101694 doi: 10.1016/j.genrep.2022.101694
|
46 |
Lin Zhao, Hong Chen, QingYi Zhang, Jin Ma, Hao Hu, Lu Xu. ATF4-mediated microRNA-145/HDAC4/p53 axis affects resistance of colorectal cancer cells to 5-fluorouracil by regulating autophagy. Cancer Chemotherapy and Pharmacology 2022; 89(5): 595 doi: 10.1007/s00280-021-04393-0
|
47 |
Amir Sadra Zangouei, Meysam Moghbeli. MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells. Genes and Environment 2021; 43(1) doi: 10.1186/s41021-021-00192-4
|
48 |
Liaoran Niu, Wanli Yang, Lili Duan, Xiaoqian Wang, Yiding Li, Chengchao Xu, Chao Liu, Yujie Zhang, Wei Zhou, Jinqiang Liu, Qingchuan Zhao, Liu Hong, Daiming Fan. Biological Implications and Clinical Potential of Metastasis-Related miRNA in Colorectal Cancer. Molecular Therapy - Nucleic Acids 2021; 23: 42 doi: 10.1016/j.omtn.2020.10.030
|
49 |
Yebin Lu, Xiaoli Zhang, Xueyu Li, Lingjie Deng, Changqiang Wei, Dongmei Yang, Xuemei Tan, Weicheng Pan, Lihong Pang. MiR-135a-5p suppresses trophoblast proliferative, migratory, invasive, and angiogenic activity in the context of unexplained spontaneous abortion. Reproductive Biology and Endocrinology 2022; 20(1) doi: 10.1186/s12958-022-00952-z
|
50 |
Feng Wu, Jiani Yang, Guoyin Shang, Zhijia Zhang, Sijia Niu, Yang Liu, Hongru Liu, Jing Jing, Yu Fang, L szl Vir g. Exosomal miR-224-5p from Colorectal Cancer Cells Promotes Malignant Transformation of Human Normal Colon Epithelial Cells by Promoting Cell Proliferation through Downregulation of CMTM4. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/5983629
|
51 |
Cigdem Gungormez, Emine Teker, Sema Atmanoglu, Ersin Borazan. miRNA Profile and Bioinformatic Analysis for Diagnosis in Patients with Stage IIIA Colon Cancer. Biochemical Genetics 2022; 60(1): 191 doi: 10.1007/s10528-021-10096-1
|
52 |
Zeeshan Javed, Muhammad Javed Iqbal, Amna Rasheed, Haleema Sadia, Shahid Raza, Asma Irshad, Wojciech Koch, Wirginia Kukula-Koch, Anna Głowniak-Lipa, William C. Cho, Javad Sharifi-Rad. Regulation of Hedgehog Signaling by miRNAs and Nanoformulations: A Possible Therapeutic Solution for Colorectal Cancer. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.607607
|
53 |
Kenneth K.W. To, William C.S. Cho. Flavonoids Overcome Drug Resistance to Cancer Chemotherapy by Epigenetically Modulating Multiple Mechanisms. Current Cancer Drug Targets 2021; 21(4): 289 doi: 10.2174/1568009621666210203111220
|
54 |
Jong Lyul Lee, Seon Ae Roh, Chan Wook Kim, Yi Hong Kwon, Ye Jin Ha, Seon-Kyu Kim, Seon-Young Kim, Dong-Hyung Cho, Yong Sung Kim, Jin Cheon Kim. Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer. World Journal of Gastroenterology 2019; 25(11): 1341-1354 doi: 10.3748/wjg.v25.i11.1341
|
55 |
Alexandra Gherman, Loredana Balacescu, Calin Popa, Calin Cainap, Catalin Vlad, Simona S. Cainap, Ovidiu Balacescu. Baseline Expression of Exosomal miR-92a-3p and miR-221-3p Could Predict the Response to First-Line Chemotherapy and Survival in Metastatic Colorectal Cancer. International Journal of Molecular Sciences 2023; 24(13): 10622 doi: 10.3390/ijms241310622
|
56 |
Naeim Ehtesham, Meysam Mosallaei, Mohammad Reza Karimzadeh, Hossein Moradikazerouni, Mohammadreza Sharifi. microRNAs: key modulators of disease-modifying therapies in multiple sclerosis. International Reviews of Immunology 2020; 39(6): 264 doi: 10.1080/08830185.2020.1779712
|
57 |
Susana Ourô, Cláudia Mourato, Marisa P. Ferreira, Diogo Albergaria, André Cardador, Rui E. Castro, Rui Maio, Cecília M. P. Rodrigues. Evaluation of Tissue and Circulating miR-21 as Potential Biomarker of Response to Chemoradiotherapy in Rectal Cancer. Pharmaceuticals 2020; 13(9): 246 doi: 10.3390/ph13090246
|
58 |
Bayan Mehrjoei, Lida Haghnazari, Homayoon Bashiri, Nayebali Rezvani. The diagnostic potential of miR-196a-1 in colorectal cancer. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-11881-y
|
59 |
Petra Vychytilova-Faltejskova, Ondrej Slaby. MicroRNA in Human Malignancies. 2022; : 203 doi: 10.1016/B978-0-12-822287-4.00007-4
|
60 |
Yuhong Ma, Yuzhen Li, Yuanyuan Tang, Ning Tang, Dengke Wang, Xiaofei Li. LINC00174 Facilitates Proliferation and Migration of Colorectal Cancer Cells via MiR-3127-5p/ E2F7 Axis. Journal of Microbiology and Biotechnology 2021; 31(8): 1098 doi: 10.4014/jmb.2103.03001
|
61 |
Davood Jafari, Farshid Noorbakhsh, Alireza Delavari, Javad Tavakkoli-Bazzaz, Samad Farashi-Bonab, Rasoul Abdollahzadeh, Nima Rezaei. Expression level of long noncoding RNA NKILA-miR103-miR107 inflammatory axis and its clinical significance as potential biomarker in patients with colorectal cancer. Journal of Research in Medical Sciences 2020; 25(1): 41 doi: 10.4103/jrms.JRMS_943_19
|
62 |
Guohua Zhou, Jinglian Xie, Zikun Gao, Weishen Yao. MicroRNA‑877 inhibits cell proliferation and invasion in non‑small cell lung cancer by directly targeting IGF‑1R. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7676
|
63 |
Hong Chen, Jun Yao, Zhili Shan, YiJun Wei, Shijie You, Dechun Li, Yi Zhang. To Assess the Role of microRNA-451 in the Progression and Metastasis of Colorectal Cancer. Applied Biochemistry and Biotechnology 2024; 196(2): 1044 doi: 10.1007/s12010-023-04538-2
|
64 |
Sayan Saha, Shreya Ghosh, Suman Ghosh, Sumit Nandi, Aditi Nayak. Unraveling the complexities of colorectal cancer and its promising therapies – An updated review. International Immunopharmacology 2024; 143: 113325 doi: 10.1016/j.intimp.2024.113325
|
65 |
Ying Zhao, Yan Zeng, Dong Zeng, Hesong Wang, Mengjia Zhou, Ning Sun, Jinge Xin, Abdul Khalique, Danish Sharafat Rajput, Kangcheng Pan, Gang Shu, Bo Jing, Xueqin Ni. Probiotics and MicroRNA: Their Roles in the Host–Microbe Interactions. Frontiers in Microbiology 2021; 11 doi: 10.3389/fmicb.2020.604462
|
66 |
Giuseppe Corrias, Eleonora Lai, Pina Ziranu, Stefano Mariani, Clelia Donisi, Nicole Liscia, Giorgio Saba, Andrea Pretta, Mara Persano, Daniela Fanni, Dario Spanu, Francesca Balconi, Francesco Loi, Simona Deidda, Angelo Restivo, Valeria Pusceddu, Marco Puzzoni, Cinzia Solinas, Elena Massa, Clelia Madeddu, Clara Gerosa, Luigi Zorcolo, Gavino Faa, Luca Saba, Mario Scartozzi. Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging. Cancers 2024; 16(7): 1364 doi: 10.3390/cancers16071364
|
67 |
Jianxin Ge, Jun Li, Su Na, Pingping Wang, Guifeng Zhao, Xiaoyan Zhang. miR‐548c‐5p inhibits colorectal cancer cell proliferation by targeting PGK1. Journal of Cellular Physiology 2019; 234(10): 18872 doi: 10.1002/jcp.28525
|
68 |
Ziyu Ning, Shuang Yu, Yanqiao Zhao, Yang Wang, Qi Fan, Tianming Song, Xiaoyang Yu. Survival Marker miRNA-Mediated Subpathways of Breast Invasive Carcinoma Derived From Activity Profile. IEEE Access 2020; 8: 160947 doi: 10.1109/ACCESS.2020.3018148
|
69 |
Ye Feng, Ying Xu, Yongjian Gao, Yiying Chen, Xuefeng Wang, Zhi Chen. A novel lncRNA SOX2OT promotes the malignancy of human colorectal cancer by interacting with miR-194-5p/SOX5 axis. Cell Death & Disease 2021; 12(5) doi: 10.1038/s41419-021-03756-y
|
70 |
Nelly O. Elshafie, Michael Gribskov, Nathanael I. Lichti, Ekramy. E. Sayedahmed, Michael O. Childress, Andrea P. dos Santos. miRNome expression analysis in canine diffuse large B-cell lymphoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1238613
|
71 |
Soumaiah Staiteieh, Laila Akil, Rawan Al Khansa, Rihab Nasr, Zainab Al Sagheer, Bilal Houshaymi, Raghida Merhi. Study of microRNA expression profiling as biomarkers for colorectal cancer patients in Lebanon. Molecular and Clinical Oncology 2021; 16(2) doi: 10.3892/mco.2021.2473
|
72 |
Hamzah H. Kzar Al‐Shukri, Sana Abdul‐Jabbar Ali, Karam Akram Al‐Akkam, Ahmed Hjazi, Irodakhon Rasulova, Yasser Fakri Mustafa, Dahlia N. Al‐Saidi, Mohammed Qasim Alasheqi, Ahmed Alawadi, Ali Alsaalamy. The role of exo‐miRNA in diagnosis and treatment of cancers, focusing on effective miRNAs in colorectal cancer. Cell Biology International 2024; 48(3): 280 doi: 10.1002/cbin.12122
|
73 |
Ines P. Nearchou, Hideki Ueno, Yoshiki Kajiwara, Kate Lillard, Satsuki Mochizuki, Kengo Takeuchi, David J. Harrison, Peter D. Caie. Automated Detection and Classification of Desmoplastic Reaction at the Colorectal Tumour Front Using Deep Learning. Cancers 2021; 13(7): 1615 doi: 10.3390/cancers13071615
|
74 |
Sumadee De Silva, Kamani Hemamala Tennekoon, Eric Hamilton Karunanayake. Interaction of Gut Microbiome and Host microRNAs with the Occurrence of Colorectal and Breast Cancer and Their Impact on Patient Immunity. OncoTargets and Therapy 2021; : 5115 doi: 10.2147/OTT.S329383
|
75 |
Serena Ascrizzi, Grazia Maria Arillotta, Katia Grillone, Giulio Caridà, Stefania Signorelli, Asad Ali, Caterina Romeo, Pierfrancesco Tassone, Pierosandro Tagliaferri. Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice. Cancers 2023; 15(15): 3930 doi: 10.3390/cancers15153930
|
76 |
Sogand Vahidi, Shahram Agah, Ebrahim Mirzajani, Elahe Asghari Gharakhyli, Seyedeh Elham Norollahi, Morteza Rahbar Taramsari, Kosar Babaei, Ali Akbar Samadani. microRNAs, oxidative stress, and genotoxicity as the main inducers in the pathobiology of cancer development. Hormone Molecular Biology and Clinical Investigation 2024; 45(2): 55 doi: 10.1515/hmbci-2023-0012
|
77 |
Milena Peruhova, Monika Peshevska-Sekulovska, Boris Krastev, Gabriela Panayotova, Viktoriya Georgieva, Rossitza Konakchieva, Georgi Nikolaev, Tsvetelina Veselinova Velikova. What could microRNA expression tell us more about colorectal serrated pathway carcinogenesis?. World Journal of Gastroenterology 2020; 26(42): 6556-6571 doi: 10.3748/wjg.v26.i42.6556
|
78 |
Zhennan Yun, Meng Yue, Zhenhua Kang, Ping Zhang. Reduced expression of microRNA-432-5p by DNA methyltransferase 3B leads to development of colorectal cancer through upregulation of CCND2. Experimental Cell Research 2022; 410(1): 112936 doi: 10.1016/j.yexcr.2021.112936
|
79 |
Yong Zhang, Wen-Shuai Liu, Xiang-Yu Zhang, Han-Xing Tong, Hua Yang, Wei-Feng Liu, Jia Fan, Jian Zhou, Jie Hu. Low expression of exosomal miR-150 predicts poor prognosis in colorectal cancer patients after surgical resections. Carcinogenesis 2022; 43(10): 930 doi: 10.1093/carcin/bgac059
|
80 |
Jessica Vilsan, Sai Aditya Maddineni, Nayab Ahsan, Midhun Mathew, Nikhila Chilakuri, Nilay Yadav, Eduardo J Munoz, Muhammad A Nadeem, Kiran Abbas, Waleed Razzaq, Zain U Abdin, Moiz Ahmed. Open, Laparoscopic, and Robotic Approaches to Treat Colorectal Cancer: A Comprehensive Review of Literature. Cureus 2023; doi: 10.7759/cureus.38956
|
81 |
Zaoqu Liu, Taoyuan Lu, Yanli Wang, Dechao Jiao, Zhaonan Li, Libo Wang, Long Liu, Chunguang Guo, Yanan Zhao, Xinwei Han. Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer. Journal of Cellular and Molecular Medicine 2021; 25(14): 6874 doi: 10.1111/jcmm.16696
|
82 |
Grzegorz Procyk, Olga Grodzka, Marcelina Procyk, Aleksandra Gąsecka, Katarzyna Głuszek, Małgorzata Wrzosek. MicroRNAs in Myocarditis—Review of the Preclinical In Vivo Trials. Biomedicines 2023; 11(10): 2723 doi: 10.3390/biomedicines11102723
|
83 |
Ji Su Mo, Won Cheol Park, Suck-Chei Choi, Ki Jung Yun, Soo-Cheon Chae. MicroRNA 452 Regulates Cell Proliferation, Cell Migration, and Angiogenesis in Colorectal Cancer by Suppressing VEGFA Expression. Cancers 2019; 11(10): 1613 doi: 10.3390/cancers11101613
|
84 |
Xiaoyun Hu, Qiuchen Chen, Hao Guo, Kuo Li, Boshi Fu, Yu Chen, Haishan Zhao, Minjie Wei, Yalun Li, Huizhe Wu. Identification of Target PTEN-Based miR-425 and miR-576 as Potential Diagnostic and Immunotherapeutic Biomarkers of Colorectal Cancer With Liver Metastasis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.657984
|
85 |
Ruliang Ding, Weiwen Hong, Liang Huang, Jinfan Shao, Wenfeng Yu, Xijuan Xu. Examination of the effects of microRNA-145-5p and phosphoserine aminotransferase 1 in colon cancer. Bioengineered 2022; 13(5): 12794 doi: 10.1080/21655979.2022.2071010
|
86 |
Jawara Allen, Cynthia L. Sears. Impact of the gut microbiome on the genome and epigenome of colon epithelial cells: contributions to colorectal cancer development. Genome Medicine 2019; 11(1) doi: 10.1186/s13073-019-0621-2
|
87 |
Sofía Elena Tesolato, Daniel González-Gamo, Ana Barabash, Paula Claver, Sofía Cristina de la Serna, Inmaculada Domínguez-Serrano, Jana Dziakova, Carmen de Juan, Antonio José Torres, Pilar Iniesta. Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the Body Mass Index. Cancers 2023; 15(13): 3324 doi: 10.3390/cancers15133324
|
88 |
Guillermo N. López-Sánchez, Eduardo Montalvo-Javé, Mayra Domínguez-Perez, Barbara Antuna-Puente, Fredy O. Beltrán-Anaya, Alfredo Hidalgo-Miranda, Norberto C. Chávez-Tapia, Misael Uribe, Natalia Nuño- Lámbarri. Hepatic mir-122-3p, mir-140-5p and mir-148b-5p expressions are correlated with cytokeratin-18 serum levels in MAFLD. Annals of Hepatology 2022; 27(6): 100756 doi: 10.1016/j.aohep.2022.100756
|
89 |
Saleheh Rezapour, Elham Hosseinzadeh, Faroogh Marofi, Ali Hassanzadeh. Epigenetic‐based therapy for colorectal cancer: Prospect and involved mechanisms. Journal of Cellular Physiology 2019; 234(11): 19366 doi: 10.1002/jcp.28658
|
90 |
Sridhar Muthusami, Ilangovan Ramachandran, Sneha Krishnamoorthy, Yuvaraj Sambandam, Satish Ramalingam, Lurdes Queimado, Gautam Chaudhuri, Ileng Kumaran Ramachandran. Regulation of MicroRNAs in Inflammation-Associated Colorectal Cancer: A Mechanistic Approach. Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21(1): 67 doi: 10.2174/1871530320666200917112802
|
91 |
Jianhua Li, Bei Gan, Lin Lu, Lihong Chen, Jianying Yan. Expression of microRNAs in patients with gestational diabetes mellitus: a systematic review and meta-analysis. Acta Diabetologica 2022; 60(4): 461 doi: 10.1007/s00592-022-02005-8
|
92 |
Mahdi Alaee, Pegah Kiyamehr, Faezeh Maroufi, Amirhosein Maali, Mehdi Azad. Dual role of microRNAs in cancer metastasis. Human Gene 2023; 38: 201218 doi: 10.1016/j.humgen.2023.201218
|
93 |
Zhengyu Lu, Jin Xu, Binhao Cao, Chongqiang Jin. Long non-coding RNA SOX21-AS1: A potential tumor oncogene in human cancers. Pathology - Research and Practice 2023; 249: 154774 doi: 10.1016/j.prp.2023.154774
|
94 |
Xiaona Lu, Yuyao Li, Yue Li, Xuemei Zhang, Jia Shi, Hai Feng, Zhuo Yu, Yueqiu Gao. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11600-z
|
95 |
Aldona Kasprzak. Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology Techniques. Cancers 2023; 15(18): 4570 doi: 10.3390/cancers15184570
|
96 |
Marwa Matboli, Nourhan Hossam, Doaa Farag, Mohamed Hassan, Hanan Shehata, Marwa Aboelhussein, Nahed Ismail, Sanaa Eissa. miRNAs: possible regulators of toll like receptors and inflammatory tumor microenvironment in colorectal cancer. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12417-0
|
97 |
Elisa Francone, Sergio Gentilli, Gregorio Santori, Cesare Stabilini, Rosario Fornaro, Marco Frascio. MicroRNAs differential expression profile in metastatic colorectal cancer: A pilot study with literature review. Surgical Oncology 2021; 37: 101524 doi: 10.1016/j.suronc.2021.101524
|
98 |
Sarah Cheuk Hei Chan, Jessie Qiaoyi Liang. Advances in tests for colorectal cancer screening and diagnosis. Expert Review of Molecular Diagnostics 2022; 22(4): 449 doi: 10.1080/14737159.2022.2065197
|
99 |
Ji-lin Li, Ke-zhi Li, Ming-zhi Xie, Yan-ping Tang, Yin-lin Tang, Bangli Hu. Clinical Significance and Prognostic Value of miR-28-5p in Colon Cancer. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/3159831
|
100 |
Yingchun Tang, Xiahui Weng, Chang Liu, Xing Li, Chao Chen, Silvia Cantara. Hypoxia Enhances Activity and Malignant Behaviors of Colorectal Cancer Cells through the STAT3/MicroRNA-19a/PTEN/PI3K/AKT Axis. Analytical Cellular Pathology 2021; 2021: 1 doi: 10.1155/2021/4132488
|
101 |
Chuangxin Lu, Lei Fu, Xiaoyan Qian, Linsen Dou, Shundong Cang. Knockdown of circular RNA circ-FARSA restricts colorectal cancer cell growth through regulation of miR-330-5p/LASP1 axis. Archives of Biochemistry and Biophysics 2020; 689: 108434 doi: 10.1016/j.abb.2020.108434
|
102 |
Ran Li, Li Jiang, Xiaoling Wang. Aberrant expression of miR‑483‑5p in patients with asymptomatic carotid artery stenosis and its predictive value for cerebrovascular event occurrence. Experimental and Therapeutic Medicine 2021; 22(4) doi: 10.3892/etm.2021.10536
|
103 |
Novel Siglec-15-Sia axis inhibitor leads to colorectal cancer cell death by targeting miR-6715b-3p and oncogenes. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1254911
|
104 |
Hongyu Dong, Qi Liu, Chaowu Chen, Tailiang Lu, Kaiwu Xu. LncRNA OGFRP1 promotes angiogenesis and epithelial-mesenchymal transition in colorectal cancer cells through miR-423-5p/CTCF axis. Immunobiology 2022; 227(2): 152176 doi: 10.1016/j.imbio.2022.152176
|
105 |
Dong-Yan Zhao, Lei Zhou, Teng-Fei Yin, Yuan-Chen Zhou, Ge-Yu-Jia Zhou, Qian-Qian Wang, Shu-Kun Yao. Circulating miR-627-5p and miR-199a-5p are promising diagnostic biomarkers of colorectal neoplasia. World Journal of Clinical Cases 2022; 10(16): 5165-5184 doi: 10.12998/wjcc.v10.i16.5165
|
106 |
Chiranjib Chakraborty, Ashish Ranjan Sharma, Garima Sharma, Sang-Soo Lee. Therapeutic advances of miRNAs: A preclinical and clinical update. Journal of Advanced Research 2021; 28: 127 doi: 10.1016/j.jare.2020.08.012
|
107 |
Sally Farouk, Ahmed Khairy, Ahmed M. Salem, Ahmed F. Soliman, Noha G. Bader El Din. Differential Expression of miR-21, miR-23a, and miR-27a, and Their Diagnostic Significance in Egyptian Colorectal Cancer Patients. Genetic Testing and Molecular Biomarkers 2020; 24(12): 825 doi: 10.1089/gtmb.2020.0184
|
108 |
Rana Talib Al-Muswie, Sabah H Enayah, Rana A Ghaleb. Synergistic effects of Cassia fistula extract combination with cisplatin on the regulation of microRNA-145 and gene expression in colon cancer cell line SW480. Medical Journal of Babylon 2023; 20(4): 670 doi: 10.4103/MJBL.MJBL_33_23
|
109 |
Hanwei Jiao, Zonglin Zheng, Xuehong Shuai, Li Wu, Jixuan Chen, Yichen Luo, Yu Zhao, Hongjun Wang, Qingzhou Huang. MicroRNA expression profiles from HEK293 cells expressing H5N1 avian influenza virus non-structural protein 1. Innate Immunity 2019; 25(2): 110 doi: 10.1177/1753425919826342
|
110 |
Ovidiu Farc, Liviuta Budisan, Ioana Berindan-Neagoe, Cornelia Braicu, Oana Zanoaga, Florin Zaharie, Victor Cristea. A Group of Tumor-Suppressive micro-RNAs Changes Expression Coordinately in Colon Cancer. Current Issues in Molecular Biology 2023; 45(2): 975 doi: 10.3390/cimb45020063
|
111 |
Fei Wang, Xichun Kang, Yaoqi Li, Jianhua Lu, Xiling Liu, Huimin Yan. Elucidating hepatocellular carcinoma progression: a novel prognostic miRNA–mRNA network and signature analysis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-55806-y
|
112 |
Sura Al-Asadi, Hiba Mansour, Ahmed Jwaid Ataimish, Rusul Al-Kahachi, Jamila Rampurawala. MicroRNAs Regulate Tumorigenesis by Downregulating SOCS3 Expression: An In silico Approach. Bioinformatics and Biology Insights 2023; 17 doi: 10.1177/11779322231193535
|
113 |
Xianming Huang, Xiaohua Shen, Lixiang Peng, Wenli Mai, Yiye Wan, Huiqing Zhang. <p>CircCSNK1G1 Contributes to the Development of Colorectal Cancer by Increasing the Expression of MYO6 via Competitively Targeting miR-455-3p</p>. Cancer Management and Research 2020; : 9563 doi: 10.2147/CMAR.S262007
|
114 |
Arindam Sain, Sakshi Sahu, Debdut Naskar. Potential of olive oil and its phenolic compounds as therapeutic intervention against colorectal cancer: a comprehensive review. British Journal of Nutrition 2022; 128(7): 1257 doi: 10.1017/S0007114521002919
|
115 |
Andrei Marian Niculae, Maria Dobre, Vlad Herlea, Florina Vasilescu, Laura Cristina Ceafalan, Bogdan Trandafir, Elena Milanesi, Mihail Eugen Hinescu. Lipid Handling Protein Gene Expression in Colorectal Cancer: CD36 and Targeting miRNAs. Life 2022; 12(12): 2127 doi: 10.3390/life12122127
|
116 |
Surendra Kumar Sagar. miR-106b as an emerging therapeutic target in cancer. Genes & Diseases 2022; 9(4): 889 doi: 10.1016/j.gendis.2021.02.002
|
117 |
Luigi Borzacchiello, Roberta Veglia Tranchese, Roberta Grillo, Roberta Arpino, Laura Mosca, Giovanna Cacciapuoti, Marina Porcelli. S-Adenosylmethionine Inhibits Colorectal Cancer Cell Migration through Mirna-Mediated Targeting of Notch Signaling Pathway. International Journal of Molecular Sciences 2022; 23(14): 7673 doi: 10.3390/ijms23147673
|
118 |
Tao Hu, Hengyang Shen, Jie Li, Peng Yang, Qiou Gu, Zan Fu. RETRACTED: RFC2, a direct target of miR‐744, modulates the cell cycle and promotes the proliferation of CRC cells. Journal of Cellular Physiology 2020; 235(11): 8319 doi: 10.1002/jcp.29676
|
119 |
Zhicheng Zhuang, Huajun Cai, Hexin Lin, Bingjie Guan, Yong Wu, Yiyi Zhang, Xing Liu, Jinfu Zhuang, Guoxian Guan, Alessandro Granito. Development and Validation of a Robust Pyroptosis-Related Signature for Predicting Prognosis and Immune Status in Patients with Colon Cancer. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/5818512
|
120 |
Surasak Wanram, Namphon Klaewkla, Parichart Pinyosri. Downregulation of Serum miR-133b and miR-206 Associate with Clinical
Outcomes of Progression as Monitoring Biomarkers for Metastasis
Colorectal Cancer Patients. MicroRNA 2024; 13(1): 56 doi: 10.2174/0122115366266024240101075745
|
121 |
Yuan-yuan Zhang, Hai-yan Xu, Jing-jing Dai. MiR-193b enhanced proliferation and migration and inhibits apoptosis through targeting RAB7A in osteosarcoma cell. Molecular & Cellular Toxicology 2021; 17(1): 69 doi: 10.1007/s13273-020-00111-8
|
122 |
Marco Vacante, Roberto Ciuni, Francesco Basile, Antonio Biondi. The Liquid Biopsy in the Management of Colorectal Cancer: An Overview. Biomedicines 2020; 8(9): 308 doi: 10.3390/biomedicines8090308
|
123 |
Simona-Ruxandra Volovat, Iolanda Augustin, Daniela Zob, Diana Boboc, Florin Amurariti, Constantin Volovat, Cipriana Stefanescu, Cati Raluca Stolniceanu, Manuela Ciocoiu, Eduard Alexandru Dumitras, Mihai Danciu, Delia Gabriela Ciobanu Apostol, Vasile Drug, Sinziana Al Shurbaji, Lucia-Georgiana Coca, Florin Leon, Adrian Iftene, Paul-Corneliu Herghelegiu. Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI. Cancers 2022; 14(19): 4834 doi: 10.3390/cancers14194834
|
124 |
Neda Shakerian, Elham Darzi-Eslam, Fatemeh Afsharnoori, Nikoo Bana, Faezeh Noorabad Ghahroodi, Mojtaba Tarin, Maysam Mard-soltani, Bahman Khalesi, Zahra Sadat Hashemi, Saeed Khalili. Therapeutic and diagnostic applications of exosomes in colorectal cancer. Medical Oncology 2024; 41(8) doi: 10.1007/s12032-024-02440-3
|
125 |
Ammad Ahmad Farooqi, Rukset Attar, Uteuliyev Yerzhan Sabitaliyevich, Nada Alaaeddine, Damião Pergentino de Sousa, Baojun Xu, William C. Cho. The Prowess of Andrographolide as a Natural Weapon in the War against Cancer. Cancers 2020; 12(8): 2159 doi: 10.3390/cancers12082159
|
126 |
Seyed Hamid Moosavy, Shabnaz Koochakkhani, Mahdi Barazesh, Shiva Mohammadi, Khadijeh Ahmadi, Behnaz Rahnama Inchehsablagh, Soudabeh Kavousipour, Ebrahim Eftekhar, Pooneh Mokaram. In silico Analysis of Single Nucleotide Polymorphisms Associated with MicroRNA
Regulating 5-fluorouracil Resistance in Colorectal Cancer. Letters in Drug Design & Discovery 2022; 19(2): 144 doi: 10.2174/1570180818666210930161618
|
127 |
Amel Taibi, Zoe Lofft, Bianca Laytouni-Imbriaco, Elena Maria Comelli. The role of intestinal microbiota and microRNAs in the anti-inflammatory effects of cranberry: from pre-clinical to clinical studies. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1092342
|
128 |
Chunrong Wu, Xiaohu Liu, Bo Li, Guiying Sun, Chunfang Peng, Debing Xiang. miR‑451 suppresses the malignant characteristics of colorectal cancer via targeting SAMD4B. Molecular Medicine Reports 2021; 24(2) doi: 10.3892/mmr.2021.12196
|
129 |
Zhe Cai, Liangyuan Suo, Zeqing Huang. Isoflurane Suppresses Proliferation, Migration, and Invasion and Facilitates Apoptosis in Colorectal Cancer Cells Through Targeting miR-216. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.658926
|
130 |
ChauMyThanh Tran, PhongSon Dinh. Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data. Journal of Biomolecular Structure and Dynamics 2024; : 1 doi: 10.1080/07391102.2024.2328744
|
131 |
Maryam Hejazi, Elham Baghbani, Mohammad Amini, Tayebeh Rezaei, Ayuob Aghanejad, Jafar Mosafer, Ahad Mokhtarzadeh, Behzad Baradaran. MicroRNA‐193a and taxol combination: A new strategy for treatment of colorectal cancer. Journal of Cellular Biochemistry 2020; 121(2): 1388 doi: 10.1002/jcb.29374
|
132 |
Bin Xu, Jie Mei, Wei Ji, Zheng Bian, Jiantong Jiao, Jun Sun, Junfei Shao. LncRNA SNHG3, a potential oncogene in human cancers. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01608-x
|
133 |
Elisa Conde, Alejandro Pascual, Daniel Prieto-Cuadra, Val F. Laza, Javier Molina-Cerrillo, Miren Edurne Ramos-Muñoz, Esperanza Macarena Rodríguez-Serrano, José Luis Soto, Alfredo Carrato, María Laura García-Bermejo, Carmen Guillén-Ponce. Novel Molecular Characterization of Colorectal Primary Tumors Based on miRNAs. Cancers 2019; 11(3): 346 doi: 10.3390/cancers11030346
|
134 |
Peng Yun, Kamila Kulaixijiang, Jiang Pan, Luping Yang, Nengzhuang Wang, Zheng Xu, Yaodong Zhang, Haifang Cai, Zi‐Ye Zhao, Min Zhu, Hongli Yan. Early colorectal cancer diagnosis: A novel methylated stool DNA model enhanced the diagnostic efficiency. United European Gastroenterology Journal 2024; doi: 10.1002/ueg2.12696
|
135 |
Nazila Mozammel, Mohammad Amini, Behzad Baradaran, Seyedeh Zahra Bahojb Mahdavi, Seyed Samad Hosseini, Ahad Mokhtarzadeh. The function of miR-145 in colorectal cancer progression; an updated review on related signaling pathways. Pathology - Research and Practice 2023; 242: 154290 doi: 10.1016/j.prp.2022.154290
|
136 |
Dina A Abo-elela, Ahmed MH Salem, Menha Swellam, Marwa GA Hegazy. Potential diagnostic role of circulating MiRNAs in colorectal cancer. International Journal of Immunopathology and Pharmacology 2023; 37 doi: 10.1177/03946320221144565
|
137 |
Adrianna Douvris, Dylan Burger, Rosendo A. Rodriguez, Edward G. Clark, Jose Viñas, Manoj M. Lalu, Risa Shorr, Kevin D. Burns. MicroRNA in Human Acute Kidney Injury: A Systematic Review Protocol. Canadian Journal of Kidney Health and Disease 2021; 8 doi: 10.1177/20543581211009999
|
138 |
Jing Lu, Jianqiang Liang, Mengting Xu, Zhipeng Wu, Wenjun Cheng, Jie Wu. Identification of an eleven-miRNA signature to predict the prognosis of endometrial cancer. Bioengineered 2021; 12(1): 4201 doi: 10.1080/21655979.2021.1952051
|
139 |
Nahal Eshghifar, Elham Badrlou, Farkhondeh Pouresmaeili. The roles of miRNAs’ clinical efficiencies in the colorectal cancer pathobiology: A review article. Human Antibodies 2020; 28(4): 273 doi: 10.3233/HAB-200417
|